(Reuters) -Insmed said on Tuesday that its experimental drug significantly reduced blood pressure in the lungs and improved exercise capacity in patients in a mid-stage study, […]

MANCHESTER — Two ongoing cardiology trials in the UK are facing substantial recruitment challenges, researchers reported at the British Cardiovascular Society (BCS) Annual Conference 2025. The […]

(Reuters) -Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies. The drug, enlicitide decanoate, is […]

(Reuters) -Merck’s oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond […]

MANCHESTER — Cardiovascular health assessments should begin much earlier, focusing on lifetime risk rather than just their 10-year projections, experts said at the British Cardiovascular Society […]

Cardiovascular disease (CVD) is the leading cause for premature mortality in patients with mental illness, particularly those with severe psychiatric disorders. The numbers bear out the […]

MANCHESTER — Thousands of people in the United Kingdom with advanced heart failure are not being referred for potentially life-saving treatments, a leading heart transplantation expert […]